Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Schimpff

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
The American Journal of Medicine|July 1, 1983
Infection among 210 patients with surgically staged Hodgkin's diseaseD D Coker, D M Morris, J J Coleman, et al.
The American Journal of Medicine|December 1, 1981
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patientsJ C Wade, S C Schimpff, K A Newman, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1985
Comparative pharmacokinetics and serum bactericidal activity of mezlocillin, ticarcillin and piperacillin, with and without gentamicinA F Viollier, H C Standiford, G L Drusano, et al.
The Journal of Infectious Diseases|April 1, 1983
Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acidJ C Wade, C A de Jongh, K A Newman, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1978
Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agentsM R Moody, M J Morris, V M Young, et al.
Clinical Pharmacy|November 1, 1982
Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patientsF J Danhauer, C L Fortner, S C Schimpff, et al.
European Journal of Clinical Microbiology|October 1, 1984
The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteersG L Drusano, H C Standiford, C I Bustamante, et al.
The New England Journal of Medicine|April 30, 1981
A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemiaJ C Wade, S C Schimpff, M T Hargadon, et al.
Infection|January 1, 1978
An analysis of group D streptococci recovered from cancer patientsV M Young, M J Morris, M R Moody, et al.
Infection|January 1, 1985
Moxalactam and piperacillin: a study of in vitro characteristics and pharmacokinetics in cancer patientsG L Drusano, C de Jongh, K Newman, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
The American Journal of Medicine|July 1, 1983
Infection among 210 patients with surgically staged Hodgkin's diseaseD D Coker, D M Morris, J J Coleman, et al.
The American Journal of Medicine|December 1, 1981
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patientsJ C Wade, S C Schimpff, K A Newman, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1985
Comparative pharmacokinetics and serum bactericidal activity of mezlocillin, ticarcillin and piperacillin, with and without gentamicinA F Viollier, H C Standiford, G L Drusano, et al.
The Journal of Infectious Diseases|April 1, 1983
Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acidJ C Wade, C A de Jongh, K A Newman, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1978
Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agentsM R Moody, M J Morris, V M Young, et al.
Clinical Pharmacy|November 1, 1982
Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patientsF J Danhauer, C L Fortner, S C Schimpff, et al.
European Journal of Clinical Microbiology|October 1, 1984
The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteersG L Drusano, H C Standiford, C I Bustamante, et al.
The New England Journal of Medicine|April 30, 1981
A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemiaJ C Wade, S C Schimpff, M T Hargadon, et al.
Infection|January 1, 1978
An analysis of group D streptococci recovered from cancer patientsV M Young, M J Morris, M R Moody, et al.
Infection|January 1, 1985
Moxalactam and piperacillin: a study of in vitro characteristics and pharmacokinetics in cancer patientsG L Drusano, C de Jongh, K Newman, et al.
Pageof 16